RMI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.753840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.770200E-01
Normal-vs-Stage2
1.038970E-01
Normal-vs-Stage3
1.266180E-01
Normal-vs-Stage4
8.523800E-01
Stage1-vs-Stage2
2.417600E-01
Stage1-vs-Stage3
1.062120E-02
Stage1-vs-Stage4
8.525400E-01
Stage2-vs-Stage3
4.26060298153175E-11
Stage2-vs-Stage4
5.712800E-01
Stage3-vs-Stage4
1.864030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.908380E-01
Normal-vs-AfricanAmerican
1.927980E-01
Normal-vs-Asian
1.653780E-01
Caucasian-vs-AfricanAmerican
7.685400E-01
Caucasian-vs-Asian
6.320200E-01
AfricanAmerican-vs-Asian
9.495600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.969950E-01
Normal-vs-Female
1.672230E-01
Male-vs-Female
7.314200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.905570E-01
Normal-vs-Age(41-60Yrs)
3.531800E-01
Normal-vs-Age(61-80Yrs)
1.479640E-01
Normal-vs-Age(81-100Yrs)
7.135500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.209800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.551800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.344400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.096210E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.541980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.249600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.328300E-02
Normal-vs-Daily Drinker
4.353600E-02
Normal-vs-Weekly Drinker
1.497550E-01
Normal-vs-Occasional Drinker
7.299800E-01
Normal-vs-Social Drinker
4.337400E-01
Non Drinker-vs-Daily Drinker
5.875800E-01
Non Drinker-vs-Weekly Drinker
9.462800E-01
Non Drinker-vs-Occasional Drinker
9.759700E-02
Non Drinker-vs-Social Drinker
9.721600E-02
Daily Drinker-vs-Weekly Drinker
7.174600E-01
Daily Drinker-vs-Occasional Drinker
5.207700E-02
Daily Drinker-vs-Social Drinker
3.931700E-02
Weekly Drinker-vs-Occasional Drinker
1.486020E-01
Weekly Drinker-vs-Social Drinker
1.730220E-01
Occasional Drinker-vs-Social Drinker
6.849000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.526800E-01
Normal-vs-Grade 2
5.786600E-01
Normal-vs-Grade 3
7.957800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.589200E-01
Grade 1-vs-Grade 3
9.244000E-01
Grade 1-vs-Grade 4
6.526800E-01
Grade 2-vs-Grade 3
5.059200E-01
Grade 2-vs-Grade 4
5.786600E-01
Grade 3-vs-Grade 4
7.957800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.068100E-02
Normal-vs-NonDiabetic
2.189600E-01
Diabetic-vs-NonDiabetic
1.016220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.500100E-02
Normal-vs-NoPancreatitis
2.057000E-01
Pancreatitis-vs-NoPancreatitis
6.544300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.352600E-01
Normal-vs-N1
1.297370E-01
N0-vs-N1
6.024000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.168400E-01
Normal-vs-TP53-NonMutant
4.803800E-01
TP53-Mutant-vs-TP53-NonMutant
7.286600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
